www.sciencedaily.com
New research suggests ibuprofen may help reduce the risk of certain cancers, particularly endometrial and bowel cancer. The drug appears to work by dampening inflammation that promotes tumor growth and interfering with genes essential for cancer cell survival. However, experts warn that long-term ibuprofen use carries significant health risks, such as cardiovascular and gastrointestinal issues. Consequently, while the findings are promising, ibuprofen should not replace established cancer prevention strategies or be taken without medical supervision.
Read More
